Log in to save to my catalogue

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particle...

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particle...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1927791343

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles

About this item

Full title

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-08, Vol.12 (8), p.e0181844

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Parkinson's disease (PD) is a progressive and currently incurable neurological disorder characterised by the loss of midbrain dopaminergic neurons and the accumulation of aggregated alpha-synuclein (a-syn). Oligomeric a-syn is proposed to play a central role in spreading protein aggregation in the brain with associated cellular toxicity contributin...

Alternative Titles

Full title

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1927791343

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1927791343

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0181844

How to access this item